{"transactions":[{"id":1071562,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-08T23:39:21.000Z","date":"2025-08-08","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were granted pursuant to the Plan. The shares underlying the stock options will vest in four (4) equal quarterly installments over a period of one year following the date of grant, subject to the reporting person's continued service as of the applicable vesting date."}],"balance_after":22000,"derivative":{"exercise_price":1,"expiration_date":"2035-08-08","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001104659-25-075796","document":"tm2522995-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465925075796/tm2522995-1_4seq1.xml","form_type":"4"}},{"id":1548013,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-05T01:47:29.000Z","date":"2024-04-02","kind":"grant","planned":false,"acquired":true,"shares":22000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These stock options were granted pursuant to the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan. The shares underlying these stock options will vest in four (4) equal quarterly installments over a period of one year following the date of grant, subject to the reporting person's continued service as of the applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options were granted pursuant to the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan. The shares underlying these stock options will vest in four (4) equal quarterly installments over a period of one year following the date of grant, subject to the reporting person's continued service as of the applicable vesting date."}],"balance_after":22000,"derivative":{"exercise_price":0.955,"expiration_date":"2034-04-02","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001104659-24-043796","document":"tm2411149-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465924043796/tm2411149-6_4seq1.xml","form_type":"4"}},{"id":1709628,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant (Right to Buy)","published_at":"2023-12-15T21:32:55.000Z","date":"2023-12-13","kind":"purchase","planned":false,"acquired":true,"shares":2631,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These securities were purchased by the reporting person in the registered direct offering of CytoSorbents Corporation (the \"Company\"), which closed on December 13, 2023. In the offering, each share of common stock, par value $0.001 per share (the \"Common Stock\") of the Company was purchased together with an accompanying warrant to purchase up to 0.35 shares of Common Stock, at a combined offering price of $1.33 per share of Common Stock and accompanying warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These securities were purchased by the reporting person in the registered direct offering of CytoSorbents Corporation (the \"Company\"), which closed on December 13, 2023. In the offering, each share of common stock, par value $0.001 per share (the \"Common Stock\") of the Company was purchased together with an accompanying warrant to purchase up to 0.35 shares of Common Stock, at a combined offering price of $1.33 per share of Common Stock and accompanying warrant."}],"balance_after":2631,"derivative":{"exercise_price":2,"exercise_date":"2023-12-13","expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":2631},"source":{"system":"sec-edgar","filing":"0001104659-23-126428","document":"tm2332958-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465923126428/tm2332958-7_4seq1.xml","form_type":"4"}},{"id":1709627,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-15T21:32:55.000Z","date":"2023-12-13","kind":"purchase","planned":false,"acquired":true,"shares":7519,"price":1.33,"value":10000.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities were purchased by the reporting person in the registered direct offering of CytoSorbents Corporation (the \"Company\"), which closed on December 13, 2023. In the offering, each share of common stock, par value $0.001 per share (the \"Common Stock\") of the Company was purchased together with an accompanying warrant to purchase up to 0.35 shares of Common Stock, at a combined offering price of $1.33 per share of Common Stock and accompanying warrant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These securities were purchased by the reporting person in the registered direct offering of CytoSorbents Corporation (the \"Company\"), which closed on December 13, 2023. In the offering, each share of common stock, par value $0.001 per share (the \"Common Stock\") of the Company was purchased together with an accompanying warrant to purchase up to 0.35 shares of Common Stock, at a combined offering price of $1.33 per share of Common Stock and accompanying warrant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (i) the following Restricted Stock Units (\"RSUs\") that will be settled into Common Stock vesting upon a \"Change In Control\" of the Company as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 55,000 RSUs granted on April 8, 2015, (b) 5,000 RSUs granted on June 7, 2016, (c) 6,000 RSUs granted on February 24, 2017 and (d) 3,300 RSUs granted on March 15, 2018; and (ii) 19,534 shares of Common Stock owned by the reporting person."}],"balance_after":88834,"source":{"system":"sec-edgar","filing":"0001104659-23-126428","document":"tm2332958-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465923126428/tm2332958-7_4seq1.xml","form_type":"4"}},{"id":1831699,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-12T00:30:57.000Z","date":"2023-07-07","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were granted pursuant to the Plan. The shares underlying the stock options shall vest in full on the first anniversary of the award date, subject to the reporting person's continued service as of the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":3.53,"expiration_date":"2033-07-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-23-080102","document":"tm2321021-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465923080102/tm2321021-4_4seq1.xml","form_type":"4"}},{"id":2187175,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-08-12T22:51:46.000Z","date":"2022-08-10","kind":"grant","acquired":true,"shares":18975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were granted pursuant to the Plan. The shares underlying the stock options will vest in four equal parts on 8/10/2022, 9/30/2022, 12/31/2022 and 3/31/2023, subject to the reporting person's continued service as of the applicable vesting date."}],"balance_after":18975,"derivative":{"exercise_price":1.95,"expiration_date":"2032-08-10","underlying":"Common Stock","underlying_shares":18975},"source":{"system":"sec-edgar","filing":"0001104659-22-090260","document":"tm2223355d8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465922090260/tm2223355d8_4seq1.xml","form_type":"4"}},{"id":2268514,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-17T20:44:39.000Z","date":"2022-05-16","kind":"purchase","acquired":true,"shares":1676,"price":2.2366,"value":3748.5416,"ownership":{"direct":true},"balance_after":81315,"source":{"system":"sec-edgar","filing":"0001104659-22-061986","document":"tm2215854d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465922061986/tm2215854d1_4seq1.xml","form_type":"4"}},{"id":2475954,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-14T00:59:47.000Z","date":"2021-12-09","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":4.125,"exercise_date":"2012-01-18","expiration_date":"2022-01-18","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001104659-21-149251","document":"tm2135306-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465921149251/tm2135306-1_4seq1.xml","form_type":"4"}},{"id":2475953,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-14T00:59:47.000Z","date":"2021-12-09","kind":"tax_withholding","acquired":false,"shares":3161,"price":5.22,"value":16500.42,"ownership":{"direct":true},"balance_after":79639,"source":{"system":"sec-edgar","filing":"0001104659-21-149251","document":"tm2135306-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465921149251/tm2135306-1_4seq1.xml","form_type":"4"}},{"id":2475952,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-14T00:59:47.000Z","date":"2021-12-09","kind":"exercise","acquired":true,"shares":4000,"price":4.125,"value":16500.0,"ownership":{"direct":true},"balance_after":82800,"source":{"system":"sec-edgar","filing":"0001104659-21-149251","document":"tm2135306-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465921149251/tm2135306-1_4seq1.xml","form_type":"4"}},{"id":2749695,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-15T01:15:22.000Z","date":"2021-04-12","kind":"grant","acquired":true,"shares":17250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were granted pursuant to the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan. The shares underlying the stock options will vest in four equal parts on 4/12/2021, 6/30/2021, 9/30/2021 and 12/31/2021, subject to the reporting person's continued service as of the applicable vesting date."}],"balance_after":17250,"derivative":{"exercise_price":8.99,"expiration_date":"2031-04-12","underlying":"Common Stock","underlying_shares":17250},"source":{"system":"sec-edgar","filing":"0001104659-21-050400","document":"tm2113016d6_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465921050400/tm2113016d6_4.xml","form_type":"4"}},{"id":3051292,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-08-20T20:10:09.000Z","date":"2020-08-18","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":3.35,"exercise_date":"2020-12-31","expiration_date":"2020-12-31","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001104659-20-097228","document":"tm2029102-1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465920097228/tm2029102-1_4.xml","form_type":"4"}},{"id":3051291,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-20T20:10:09.000Z","date":"2020-08-18","kind":"exercise","acquired":true,"shares":4000,"price":3.35,"value":13400.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes: (i) the following RSUs that will be settled into common stock upon vesting upon a \"Change In Control\" of CytoSorbents Corporation (the \"Company\") as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 55,000 RSUs granted on April 8, 2015, (b) 5,000 RSUs granted on June 7, 2016, (c) 6,000 RSUs granted on February 24, 2017 and (d) 3,300 RSUs granted on March 15, 2018; and (ii) 9,500 shares of common stock owned by the reporting person."}],"balance_after":78800,"source":{"system":"sec-edgar","filing":"0001104659-20-097228","document":"tm2029102-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465920097228/tm2029102-1_4.xml","form_type":"4"}},{"id":3233281,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-03-03T22:00:46.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Includes 15,000 stock options granted on 2/28/2020 and reported on this Form 4. These options were granted pursuant to the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan and will vest in four equal parts on 3/31/2020, 6/30/2020, 9/30/2020 and 12/31/2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 15,000 stock options granted on 2/28/2020 and reported on this Form 4. These options were granted pursuant to the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan and will vest in four equal parts on 3/31/2020, 6/30/2020, 9/30/2020 and 12/31/2020."}],"balance_after":15000,"derivative":{"exercise_price":6.03,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-20-028652","document":"tm2011575d6_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465920028652/tm2011575d6_form4.xml","form_type":"4"}},{"id":3456845,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-07-25T00:17:16.000Z","date":"2019-07-22","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such options were granted pursuant to the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan and vest in four equal parts at the end of each calendar quarter.  The grant gives effect to vesting which was to occur on March 31, 2019 and June 30, 2019.  The remaining portion of the grant will vest on September 30, 2019 and December 31, 2019."}],"balance_after":15000,"derivative":{"exercise_price":7.33,"expiration_date":"2029-07-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001144204-19-035837","document":"tv525803_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420419035837/tv525803_4.xml","form_type":"4"}},{"id":3657204,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-14T22:20:33.000Z","date":"2018-08-14","kind":"exercise","acquired":false,"shares":1200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2,"exercise_date":"2008-12-31","expiration_date":"2018-12-31","underlying":"Common Stock","underlying_shares":1200},"source":{"system":"sec-edgar","filing":"0001144204-19-008362","document":"tv513835_5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420419008362/tv513835_5.xml","form_type":"5"}},{"id":3657203,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-14T22:20:33.000Z","date":"2018-05-31","kind":"exercise","acquired":false,"shares":1800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.875,"exercise_date":"2008-06-25","expiration_date":"2018-06-25","underlying":"Common Stock","underlying_shares":1800},"source":{"system":"sec-edgar","filing":"0001144204-19-008362","document":"tv513835_5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420419008362/tv513835_5.xml","form_type":"5"}},{"id":3657202,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-14T22:20:33.000Z","date":"2018-08-14","kind":"exercise","acquired":true,"shares":1200,"price":2,"value":2400.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (a) the following restricted stock units subject to vesting upon a \"Change in Control\" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan: (i) 3,300 restricted stock units granted on March 15, 2018, (ii) 6,000 restricted stock units granted on February 24, 2017, (iii) 5,000 restricted stock units granted on June 7, 2016, and (iv) 55,000 restricted stock units granted on April 8, 2015, and (b) 5,500 shares of common stock owned by the reporting person."}],"balance_after":74800,"source":{"system":"sec-edgar","filing":"0001144204-19-008362","document":"tv513835_5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420419008362/tv513835_5.xml","form_type":"5"}},{"id":3657201,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-14T22:20:33.000Z","date":"2018-05-31","kind":"exercise","acquired":true,"shares":1800,"price":0.875,"value":1575.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (a) the following restricted stock units subject to vesting upon a \"Change in Control\" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan: (i) 3,300 restricted stock units granted on March 15, 2018, (ii) 6,000 restricted stock units granted on February 24, 2017, (iii) 5,000 restricted stock units granted on June 7, 2016, and (iv) 55,000 restricted stock units granted on April 8, 2015, and (b) 5,500 shares of common stock owned by the reporting person."}],"balance_after":73600,"source":{"system":"sec-edgar","filing":"0001144204-19-008362","document":"tv513835_5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420419008362/tv513835_5.xml","form_type":"5"}},{"id":3955089,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-04-27T15:41:49.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":14450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Such options were granted pursuant to the Plan and vest in four equal parts at the end of each calendar quarter beginning January 1, 2018."}],"balance_after":14450,"derivative":{"exercise_price":7.9,"expiration_date":"2028-03-15","underlying":"Common Stock","underlying_shares":14450},"source":{"system":"sec-edgar","filing":"0001144204-18-022968","document":"tv492275_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420418022968/tv492275_4.xml","form_type":"4"}},{"id":3955088,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-27T15:41:49.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units and will be settled into common stock upon vesting upon a \"Change in Control\" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the \"Plan\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) the following restricted stock units subject to vesting in accordance with the schedule set forth in (1) above: (i) 3,300 restricted stock units granted on March 15, 2018 and reported on this Form 4, (ii) 6,000 restricted stock units granted on February 24, 2017, (iii) 5,000 restricted stock units granted on June 7, 2016, and (iv) 55,000 restricted stock units granted on April 8, 2015, and (b) 2,500 shares of common stock owned by the reporting person."}],"balance_after":71800,"source":{"system":"sec-edgar","filing":"0001144204-18-022968","document":"tv492275_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420418022968/tv492275_4.xml","form_type":"4"}},{"id":4288571,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-08T22:37:38.000Z","date":"2017-06-08","kind":"purchase","acquired":true,"shares":2000,"price":3.9995,"value":7999.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) the following restricted stock units (\"RSUs\") that will be settled into common stock upon vesting upon a \"Change In Control\" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 6,000 RSUs granted on February 24, 2017, (b) 5,000 RSUs granted on June 7, 2016, and (c) 55,000 RSUs granted on April 8, 2015, and (ii) 2,500 shares of common stock purchased by the reporting person in the open market and reported on this Form 4."}],"balance_after":68500,"source":{"system":"sec-edgar","filing":"0001144204-17-031784","document":"v468718_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420417031784/v468718_4.xml","form_type":"4"}},{"id":4288570,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-08T22:37:38.000Z","date":"2017-06-08","kind":"purchase","acquired":true,"shares":500,"price":3.975,"value":1987.5,"ownership":{"direct":true},"balance_after":500,"source":{"system":"sec-edgar","filing":"0001144204-17-031784","document":"v468718_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420417031784/v468718_4.xml","form_type":"4"}},{"id":4418546,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-02-28T22:19:40.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Such options were granted pursuant to the CytoSorbents Corporation 2014 Long-Term Incentive Plan, which vest in four equal parts at the end of each calendar quarter beginning April 1, 2017."}],"balance_after":13750,"derivative":{"exercise_price":5.6,"expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":13750},"source":{"system":"sec-edgar","filing":"0001144204-17-011830","document":"v460707_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420417011830/v460707_4.xml","form_type":"4"}},{"id":4418545,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":76778,"kind":"person","name":"Jones Edward Raymond","position":1,"cik":"0001396246","reported_name":"Jones Edward Raymond","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-28T22:19:40.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units and will be settled into common stock upon vesting upon a \"Change In Control\" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 6,000 restricted stock units granted on February 24, 2017 and reported on this Form 4, (ii) 5,000 restricted stock units granted on June 7, 2016, subject to vesting in accordance with the schedule set forth in (1) above and (iii) 55,000 restricted stock units granted on April 8, 2015, subject to vesting in accordance with the schedule set forth in (1) above."}],"balance_after":66000,"source":{"system":"sec-edgar","filing":"0001144204-17-011830","document":"v460707_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420417011830/v460707_4.xml","form_type":"4"}}]}